A novel patient-derived xenograft model for claudin-low triple negative breast cancer

BACKGROUND: Triple negative breast cancer (TNBC) subtypes are clinically aggressive and are treated with targeted therapeutics commonly used in other BC subtypes. The claudin-low (CL) molecular subtype of TNBC has high rates of metastases, chemoresistance and recurrence. There exists an urgent need...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast Cancer Res Treat
Main Authors: Matossian, Margarite D., Burks, Hope E., Bowles, Annie C., Elliott, Steven, Hoang, Van T., Sabol, Rachel A., Pashos, Nicholas, O’Donnell, Benjamen, Miller, Kristin S., Wahba, Bahia M., Bunnell, Bruce A., Moroz, Krzysztof, Zea, Arnold H., Jones, Steven D., Ochoa, Augusto C., Al-Khami, Amir, Hossain, Fokhrul, Riker, Adam I., Rhodes, Lyndsay V., Martin, Elizabeth C., Miele, Lucio, Burow, Matthew E., Collins-Burow, Bridgette M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5948145/
https://ncbi.nlm.nih.gov/pubmed/29392581
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-018-4685-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados